M&A: Imprivata Acquires Patient Privacy Intelligence Company FairWarning

What You Should Know:

– Imprivata acquires FairWarning Technologies, a provider
of patient privacy intelligence.

– The combined solutions will offer healthcare a single Digital Identity platform that integrates role-based access controls, identity governance, and data privacy compliance.

Imprivata®, the digital identity company for healthcare, today announced the acquisition
of FairWarning
Technologies, LLC, a Clearwater, FL-based provider of patient privacy intelligence. The
combination of Imprivata and FairWarning
solutions provide customers with a single Digital Identity platform that
integrates role-based access controls, robust identity
governance, and critical data privacy compliance.

Patient Privacy
Intelligence Platform

FairWarning is an analytics and insider threat detection platform. The platform ingests hundreds of data sources, such as EMR, CRM, HR, and others, and applies data logic and machine learning to identify potential breaches of protected information. Primarily serving the healthcare market, FairWarning is the leader of Patient Data Privacy Intelligence and Drug Diversion analytics that serves compliance officers in the protection of Protected Health Information (PHI). FairWarning also provides similar data privacy solutions specifically designed for mission-critical business applications for enterprise and financial services.

“Like Imprivata, FairWarning is focused on delivering a world-class experience that ensures customers benefit from the full value of the investment in their solutions,” said Gus Malezis, CEO of Imprivata. “I’m thrilled about the similarities we share in culture and in our commitment to our customers. We’re excited to make FairWarning a key component of our go-forward analytics and Digital Identity strategy, and to be able to offer our customers a broader set of solutions from a single vendor that is committed to delivering innovative products and a signature customer experience.”

Show CommentsClose Comments

Leave a comment